PB2027: EFFICACY OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME WITH UNFAVORABLE IMMUNOPHENOTYPIC AND CYTOGENETIC PROGNOSIS.
Main Authors: | Hanna Trubkina, Ihar Iskrou, Iryna Lendzina, Tatiana Lebedeva, Viktirya Smolnikova |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000974916.51447.bd |
Similar Items
-
P782: IMMUNOPHENOTYPIC AND MOLECULAR GENETIC MARKERS OF UNFAVORABLE PROGNOSIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
by: H. Trubkina, et al.
Published: (2022-06-01) -
Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes
by: Minh Phuong Vu, et al.
Published: (2022-01-01) -
2027
by: Shuangge Ma, et al.
Published: (2017-09-01) -
PB1996: CYTOGENETIC FEATURES OF 164 MOROCCAN PATIENTS WITH MYELODYSPLASTIC SYNDROME
by: Yossra Aghoutane, et al.
Published: (2023-08-01) -
PB2023: UPDATE AND FOLLOW-UP OF NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) WITH HIGH-RISK CYTOGENETIC (HRC).
by: M. I. Nuevo López, et al.
Published: (2022-06-01)